Wunderlich Capital Managemnt Amgen Inc Transaction History

Wunderlich Capital Managemnt

$212 Million
Q2 2024

A detailed history of Wunderlich Capital Managemnt transactions in Amgen Inc stock. As of the latest transaction made, Wunderlich Capital Managemnt holds 9,198 shares of AMGN stock, worth $2.71 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares

9,198

Previous 8,782 4.74%

Holding current value

$2.71 Million

Previous $2.5 Million 15.1%

% of portfolio

1.35%

Previous 1.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $109,304 - $132,832	416 Added 4.74%	9,198 $2.87 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $136,585 - $164,876	-508 Reduced 5.47%	8,782 $2.5 Million
Q4 2023 Feb 15, 2024	SELL	$255.7 - $288.46 $33,241 - $37,499	-130 Reduced 1.38%	9,290 $2.68 Million
Q3 2023 Nov 15, 2023	BUY	$218.65 - $271.46 $1.51 Million - $1.87 Million	6,888 Added 272.04%	9,420 $2.53 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $1.51 Million - $1.88 Million	-6,920 Reduced 73.21%	2,532 $2.53 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $84,208 - $99,574	393 Added 4.34%	9,452 $2.1 Million
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $4,967 - $6,054	-22 Reduced 0.24%	9,059 $2.19 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $19,467 - $24,735	-85 Reduced 0.93%	9,081 $2.39 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $3,142 - $3,544	14 Added 0.15%	9,166 $2.07 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $38,759 - $43,132	-168 Reduced 1.8%	9,152 $2.23 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $17,322 - $19,163	-79 Reduced 0.84%	9,320 $2.25 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $79,750 - $91,267	-401 Reduced 4.09%	9,399 $2.11 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $68,775 - $80,578	324 Added 3.42%	9,800 $2.08 Million
Q2 2021 Aug 17, 2021	SELL	$233.58 - $259.14 $7,007 - $7,774	-30 Reduced 0.32%	9,476 $2.31 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $32,176 - $37,497	-145 Reduced 1.5%	9,506 $2.37 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $7,789 - $9,276	-36 Reduced 0.37%	9,651 $2.22 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $11,263 - $12,525	-48 Reduced 0.49%	9,687 $2.46 Million
Q2 2020 Aug 17, 2020	SELL	$197.81 - $242.74 $5,340 - $6,553	-27 Reduced 0.28%	9,735 $2.3 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $85,652 - $113,599	-470 Reduced 4.59%	9,762 $1.98 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $12,866 - $16,537	-68 Reduced 0.66%	10,232 $2.47 Million
Q3 2019 Nov 15, 2019	SELL	$174.11 - $208.62 $4,700 - $5,632	-27 Reduced 0.26%	10,300 $1.99 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $57,178 - $67,025	343 Added 3.44%	10,327 $1.9 Million
Q1 2019 May 16, 2019	BUY	$180.87 - $203.88 $27,130 - $30,582	150 Added 1.53%	9,984 $1.9 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $8,741 - $10,204	-49 Reduced 0.5%	9,834 $1.91 Million
Q3 2018 Nov 15, 2018	SELL	$185.29 - $208.89 $116,176 - $130,974	-627 Reduced 5.97%	9,883 $2.05 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $17,269 - $19,397	104 Added 1.0%	10,510 $1.94 Million
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $15,248 - $17,820	-90 Reduced 0.86%	10,406 $1.77 Million
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $18,060 - $20,179	107 Added 1.03%	10,496 $1.83 Million
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $1.74 Million - $1.98 Million	10,389	10,389 $1.94 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wunderlich Capital Managemnt, based on Form 13F filings with the SEC.

News

Stay updated on Wunderlich Capital Managemnt with notifications on news.

Account

Wunderlich Capital Managemnt Amgen Inc Transaction History